Published in Medical Letter on the CDC and FDA, April 5th, 2009
"To determine the impact of KTZ regimens on CYP3A inhibition, we simulated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA